Drug
Azilsartan medoxomil clinical trials
Also written Edarbi and TAK-491.
Keep track of what changes. Save the azilsartan medoxomil studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
25 studies that test it; most in 2007 (7)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2007 | 7 |
| 2008 | 2 |
| 2009 | 4 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 3 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 23 · Other 2
Takeda (22) · University of Chicago (1) · Baylor Research Institute (1) · Gedeon Richter Plc. (1)
Often tested with
Tested in the same studies.
Chlorthalidone (7) · Olmesartan (2) · Hydrochlorothiazide (1) · Amlodipine (1) · Finerenone (1) · Semaglutide (1) · Benazepril (1) · Captopril (1)
Studies
Open first, then newest update. How each study uses azilsartan medoxomil is read from its arms, and is right about nine times in ten.
Testing it · 25
- Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)Enrolling by invitationPhase 4Baylor Research InstituteNCT07547878Written as Edarbi
- Bioequivalence Study of Azilsartan Medoxomil 80 mg Tablets (Gedeon Richter Plc., Hungary) and Edarbi® 80 mg Tablets (JSC Nizhpharm, Russia)Not yet recruitingPhase 1Gedeon Richter Plc.NCT06990204Written as Azilsartan medoxomil 80 mg tablet
- A Single- and Multiple-Dose Study of the Pharmacokinetics of TAK-491 in Healthy Chinese ParticipantsCompletedPhase 1TakedaNCT02541669Written as TAK-491
- Azilsartan Medoxomil (TAK-491) Compared to Valsartan in Chinese Participants With HypertensionCompletedPhase 3TakedaNCT02480764Written as Azilsartan medoxomil
- Azilsartan Medoxomil in the Treatment of Essential Hypertension and Type 2 Diabetes in AsiaCompletedPhase 4TakedaNCT02517866Written as Azilsartan Medoxomil
- Effect of Azilsartan on Aldosterone in Postmenopausal FemalesCompletedNot applicableUniversity of ChicagoNCT01774591Written as Azilsartan medoximil
- Azilsartan Medoxomil (TAK-491) Compared to Placebo in Korean Adults With HypertensionCompletedPhase 3TakedaNCT02203916Written as Azilsartan medoxomil
- Efficacy and Safety of Azilsartan Medoxomil Used in Combination With Metformin in Participants With Hypertension and DiabetesTerminatedPhase 3TakedaNCT01496430Written as Azilsartan medoxomil
- A Comparative Single-Dose Pharmacokinetic (PK) and Safety Study of Azilsartan Medoxomil in Children With Hypertension and in Healthy AdultsTerminatedPhase 1TakedaNCT01078376Written as Azilsartan medoxomil (TAK-491)
- Long-Term Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Hypertension and Kidney DiseaseCompletedPhase 3TakedaNCT01309828Written as Azilsartan medoxomil and chlorthalidone
- Efficacy and Safety Study of Azilsartan Medoxomil Compared to Ramipril for Treating Essential HypertensionCompletedPhase 3TakedaNCT00760214Written as Azilsartan medoxomil
- Safety and Tolerability of Azilsartan Medoxomil Plus Chlorthalidone Compared to Olmesartan Medoxomil Plus Hydrochlorothiazide in Participants With Essential HypertensionCompletedPhase 3TakedaNCT00996281Written as Azilsartan medoxomil and chlorthalidone
- Efficacy and Safety of Azilsartan Medoxomil Plus Chlorthalidone in Participants With Moderate to Severe HypertensionCompletedPhase 3TakedaNCT00846365Written as Azilsartan medoxomil and chlorthalidone
- Efficacy and Safety of Azilsartan Medoxomil Combined With Chlorthalidone in Participants With Moderate to Severe HypertensionCompletedPhase 3TakedaNCT00847626Written as Azilsartan medoxomil and chlorthalidone
- Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone in Participants With Moderate to Severe HypertensionCompletedPhase 3TakedaNCT00818883Written as Azilsartan medoxomil and chlorthalidone
- Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Moderate to Severe Hypertension.CompletedPhase 3TakedaNCT01033071Written as Azilsartan medoxomil and chlorthalidone
- Efficacy and Safety Comparison of Azilsartan Medoxomil to Valsartan in Participants With Essential HypertensionCompletedPhase 3TakedaNCT00591578Written as Azilsartan Medoxomil
- A Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential HypertensionCompletedPhase 3TakedaNCT00696384Written as Azilsartan medoxomil
- Efficacy and Safety of Azilsartan Medoxomil in Participants With Essential HypertensionCompletedPhase 3TakedaNCT00696241Written as Azilsartan medoxomil and olmesartan
- Efficacy and Safety of Azilsartan Medoxomil, Once Daily (QD), Co-Administered With Amlodipine in Participants With Essential HypertensionCompletedPhase 3TakedaNCT00591266Written as Azilsartan Medoxomil and amlodipine
Codes
What other systems call azilsartan medoxomil · ClinicalTrials.gg INT005801
- MeSH (NLM) C557413azilsartan medoxomilConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) LL0G25K7I2AZILSARTAN MEDOXOMILConfirmed FDA, NLM, Wikidata
- RxNorm 1091642Confirmed FDA, Wikidata
- Wikidata Q1087888azilsartan medoxomilConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C75110Azilsartan MedoxomilOne source FDA
- DrugBank DB08822One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C557413 | azilsartan medoxomil | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | LL0G25K7I2 | AZILSARTAN MEDOXOMIL | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1091642 | — | Confirmed FDA, Wikidata |
| Wikidata | Q1087888 | azilsartan medoxomil | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C75110 | Azilsartan Medoxomil | One source FDA |
| DrugBank | DB08822 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.